Fig. 4
From: Legumain is an independent predictor for invasive recurrence in breast ductal carcinoma in situ
Forest plots showing the hazard ratio of the different clinicopathological parameters and ipsilateral tumor recurrence for patients treated with breast-conserving surgery in pure DCIS cohort based on the multivariate analysis results for: a all recurrences whether DCIS or invasive breast cancer and b for invasive recurrences only
